NKTR logo

Nektar Therapeutics (NKTR) Net income

annual net income:

-$118.96M+$157.09M(+56.91%)
December 31, 2024

Summary

  • As of today (September 16, 2025), NKTR annual net profit is -$118.96 million, with the most recent change of +$157.09 million (+56.91%) on December 31, 2024.
  • During the last 3 years, NKTR annual net income has risen by +$404.88 million (+77.29%).
  • NKTR annual net income is now -117.46% below its all-time high of $681.31 million, reached on December 31, 2018.

Performance

NKTR Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNKTRincome statement metrics

quarterly net income:

-$41.59M+$9.29M(+18.26%)
June 30, 2025

Summary

  • As of today (September 16, 2025), NKTR quarterly net profit is -$41.59 million, with the most recent change of +$9.29 million (+18.26%) on June 30, 2025.
  • Over the past year, NKTR quarterly net income has increased by +$10.77 million (+20.57%).
  • NKTR quarterly net income is now -104.28% below its all-time high of $971.46 million, reached on June 30, 2018.

Performance

NKTR quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNKTRincome statement metrics

TTM net income:

-$122.27M+$10.77M(+8.10%)
June 30, 2025

Summary

  • As of today (September 16, 2025), NKTR TTM net profit is -$122.27 million, with the most recent change of +$10.77 million (+8.10%) on June 30, 2025.
  • Over the past year, NKTR TTM net income has increased by +$54.81 million (+30.95%).
  • NKTR TTM net income is now -113.54% below its all-time high of $902.71 million, reached on June 30, 2018.

Performance

NKTR TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNKTRincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

NKTR Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+56.9%+20.6%+30.9%
3 y3 years+77.3%+73.8%+76.7%
5 y5 years+73.0%+48.0%+71.5%

NKTR Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+77.3%-672.8%+73.8%-2.8%+76.7%
5 y5-yearat high+77.3%-672.8%+73.8%-2.8%+76.7%
alltimeall time-117.5%+77.3%-104.3%+73.8%-113.5%+76.7%

NKTR Net income History

DateAnnualQuarterlyTTM
Jun 2025
-
-$41.59M(-18.3%)
-$122.27M(-8.1%)
Mar 2025
-
-$50.88M(-800.8%)
-$133.04M(+11.8%)
Dec 2024
-$118.96M(-56.9%)
$7.26M(-119.6%)
-$118.96M(-29.3%)
Sep 2024
-
-$37.06M(-29.2%)
-$168.30M(-5.0%)
Jun 2024
-
-$52.36M(+42.3%)
-$177.08M(+0.7%)
Mar 2024
-
-$36.80M(-12.5%)
-$175.84M(-36.3%)
Dec 2023
-$276.06M(-25.0%)
-$42.08M(-8.2%)
-$276.06M(-6.0%)
Sep 2023
-
-$45.84M(-10.3%)
-$293.67M(-4.3%)
Jun 2023
-
-$51.12M(-62.7%)
-$306.88M(-26.0%)
Mar 2023
-
-$137.02M(+129.6%)
-$414.82M(+12.7%)
Dec 2022
-$368.20M(-29.7%)
-$59.69M(+1.1%)
-$368.20M(-18.9%)
Sep 2022
-
-$59.05M(-62.9%)
-$454.15M(-13.5%)
Jun 2022
-
-$159.07M(+76.0%)
-$524.81M(+6.8%)
Mar 2022
-
-$90.39M(-37.9%)
-$491.26M(-6.2%)
Dec 2021
-$523.84M(+17.9%)
-$145.65M(+12.3%)
-$523.84M(+5.7%)
Sep 2021
-
-$129.71M(+3.3%)
-$495.39M(+4.5%)
Jun 2021
-
-$125.52M(+2.1%)
-$474.27M(+10.6%)
Mar 2021
-
-$122.97M(+4.9%)
-$428.76M(-3.5%)
Dec 2020
-$444.44M(+0.9%)
-$117.20M(+7.9%)
-$444.44M(+1.1%)
Sep 2020
-
-$108.59M(+35.7%)
-$439.40M(+2.3%)
Jun 2020
-
-$80.00M(-42.3%)
-$429.40M(-6.6%)
Mar 2020
-
-$138.65M(+23.6%)
-$459.69M(+4.3%)
Dec 2019
-$440.67M(-164.7%)
-$112.16M(+13.8%)
-$440.67M(+3.3%)
Sep 2019
-
-$98.58M(-10.6%)
-$426.71M(+0.6%)
Jun 2019
-
-$110.29M(-7.8%)
-$424.27M(-164.5%)
Mar 2019
-
-$119.63M(+21.8%)
$657.47M(-3.5%)
Dec 2018
$681.31M(-804.6%)
-$98.21M(+2.2%)
$681.31M(-8.6%)
Sep 2018
-
-$96.14M(-109.9%)
$745.70M(-17.4%)
Jun 2018
-
$971.46M(-1114.1%)
$902.71M(-801.9%)
Mar 2018
-
-$95.79M(+183.2%)
-$128.62M(+33.0%)
Dec 2017
-$96.69M(-37.0%)
-$33.83M(-155.6%)
-$96.69M(-8.0%)
Sep 2017
-
$60.87M(-201.7%)
-$105.06M(-49.8%)
Jun 2017
-
-$59.87M(-6.3%)
-$209.16M(+5.7%)
Mar 2017
-
-$63.87M(+51.3%)
-$197.89M(+28.9%)
Dec 2016
-$153.52M(+89.1%)
-$42.20M(-2.4%)
-$153.52M(-7.2%)
Sep 2016
-
-$43.22M(-11.1%)
-$165.46M(+26.8%)
Jun 2016
-
-$48.60M(+149.3%)
-$130.44M(-3.0%)
Mar 2016
-
-$19.50M(-64.0%)
-$134.50M(+65.7%)
Dec 2015
-$81.18M(+50.6%)
-$54.14M(+560.0%)
-$81.18M(+11.6%)
Sep 2015
-
-$8.20M(-84.4%)
-$72.72M(-1295.1%)
Jun 2015
-
-$52.66M(-255.7%)
$6.08M(-76.7%)
Mar 2015
-
$33.82M(-174.0%)
$26.11M(-148.4%)
Dec 2014
-$53.92M(-66.7%)
-$45.68M(-164.7%)
-$53.92M(-3.5%)
Sep 2014
-
$70.61M(-316.3%)
-$55.89M(-60.9%)
Jun 2014
-
-$32.64M(-29.4%)
-$143.04M(-6.6%)
Mar 2014
-
-$46.20M(-3.1%)
-$153.15M(-5.5%)
Dec 2013
-$162.01M(-5.7%)
-$47.66M(+188.1%)
-$162.01M(-3.1%)
Sep 2013
-
-$16.54M(-61.3%)
-$167.28M(-13.9%)
Jun 2013
-
-$42.75M(-22.4%)
-$194.28M(+4.6%)
Mar 2013
-
-$55.06M(+4.0%)
-$185.82M(+8.1%)
Dec 2012
-$171.85M(+28.3%)
-$52.93M(+21.5%)
-$171.85M(+9.9%)
Sep 2012
-
-$43.55M(+27.0%)
-$156.42M(+14.2%)
Jun 2012
-
-$34.28M(-16.6%)
-$136.94M(-1.5%)
Mar 2012
-
-$41.10M(+9.6%)
-$139.04M(+3.8%)
Dec 2011
-$133.98M(+253.1%)
-$37.49M(+55.8%)
-$133.98M(+12.5%)
Sep 2011
-
-$24.07M(-33.8%)
-$119.06M(+14.8%)
Jun 2011
-
-$36.38M(+1.0%)
-$103.71M(+52.9%)
Mar 2011
-
-$36.03M(+59.6%)
-$67.84M(+78.8%)
Dec 2010
-$37.94M(-63.0%)
-$22.58M(+159.2%)
-$37.94M(+64.7%)
Sep 2010
-
-$8.71M(+1584.9%)
-$23.03M(-49.1%)
Jun 2010
-
-$517.00K(-91.6%)
-$45.29M(-41.1%)
Mar 2010
-
-$6.13M(-20.1%)
-$76.84M(-25.0%)
Dec 2009
-$102.52M
-$7.68M(-75.2%)
-$102.52M(+467.6%)
DateAnnualQuarterlyTTM
Sep 2009
-
-$30.97M(-3.4%)
-$18.06M(-25.2%)
Jun 2009
-
-$32.07M(+0.8%)
-$24.13M(-5.1%)
Mar 2009
-
-$31.81M(-141.4%)
-$25.44M(-25.9%)
Dec 2008
-$34.34M(+4.8%)
$76.78M(-307.3%)
-$34.34M(-52.4%)
Sep 2008
-
-$37.04M(+11.0%)
-$72.08M(+34.3%)
Jun 2008
-
-$33.38M(-18.0%)
-$53.66M(+12.3%)
Mar 2008
-
-$40.70M(-204.3%)
-$47.79M(+45.9%)
Dec 2007
-$32.76M(-78.8%)
$39.04M(-309.7%)
-$32.76M(-70.4%)
Sep 2007
-
-$18.62M(-32.3%)
-$110.66M(-0.9%)
Jun 2007
-
-$27.51M(+7.2%)
-$111.64M(-24.0%)
Mar 2007
-
-$25.67M(-33.9%)
-$146.96M(-5.0%)
Dec 2006
-$154.76M(-16.4%)
-$38.85M(+98.2%)
-$154.76M(-31.0%)
Sep 2006
-
-$19.60M(-68.8%)
-$224.15M(-1.8%)
Jun 2006
-
-$62.83M(+87.7%)
-$228.34M(+18.7%)
Mar 2006
-
-$33.47M(-69.1%)
-$192.42M(+3.9%)
Dec 2005
-$185.11M(+81.7%)
-$108.24M(+354.9%)
-$185.11M(+92.5%)
Sep 2005
-
-$23.80M(-11.6%)
-$96.14M(+3.6%)
Jun 2005
-
-$26.91M(+2.9%)
-$92.80M(+5.4%)
Mar 2005
-
-$26.16M(+35.8%)
-$88.05M(-13.6%)
Dec 2004
-$101.89M(+118.3%)
-$19.27M(-5.8%)
-$101.89M(+28.8%)
Sep 2004
-
-$20.45M(-7.7%)
-$79.10M(+4.3%)
Jun 2004
-
-$22.16M(-44.6%)
-$75.86M(+13.7%)
Mar 2004
-
-$40.00M(-1239.0%)
-$66.73M(+43.0%)
Dec 2003
-$46.68M(-56.6%)
$3.51M(-120.4%)
-$46.68M(-42.6%)
Sep 2003
-
-$17.21M(+32.0%)
-$81.27M(-10.3%)
Jun 2003
-
-$13.04M(-34.6%)
-$90.58M(-11.5%)
Mar 2003
-
-$19.95M(-35.8%)
-$102.36M(-4.8%)
Dec 2002
-$107.47M(-57.0%)
-$31.07M(+17.2%)
-$107.47M(-4.6%)
Sep 2002
-
-$26.52M(+6.9%)
-$112.65M(-0.4%)
Jun 2002
-
-$24.82M(-1.0%)
-$113.05M(-41.7%)
Mar 2002
-
-$25.06M(-30.9%)
-$194.02M(-22.4%)
Dec 2001
-$250.01M(+156.7%)
-$36.25M(+34.7%)
-$250.01M(-1.3%)
Sep 2001
-
-$26.92M(-74.6%)
-$253.37M(+5.7%)
Jun 2001
-
-$105.79M(+30.5%)
-$239.66M(+60.2%)
Mar 2001
-
-$81.04M(+104.6%)
-$149.61M(+53.6%)
Dec 2000
-$97.40M(+153.3%)
-$39.61M(+199.7%)
-$97.40M(+24.9%)
Sep 2000
-
-$13.21M(-16.1%)
-$77.97M(+8.6%)
Jun 2000
-
-$15.75M(-45.4%)
-$71.80M(+15.7%)
Mar 2000
-
-$28.83M(+42.9%)
-$62.06M(+61.4%)
Dec 1999
-$38.45M(+109.5%)
-$20.17M(+186.4%)
-$38.45M(+56.4%)
Sep 1999
-
-$7.04M(+17.3%)
-$24.59M(+8.9%)
Jun 1999
-
-$6.01M(+15.0%)
-$22.59M(+16.2%)
Mar 1999
-
-$5.22M(-17.3%)
-$19.43M(+5.9%)
Dec 1998
-$18.36M(+83.9%)
-$6.32M(+25.2%)
-$18.36M(+22.1%)
Sep 1998
-
-$5.04M(+76.9%)
-$15.03M(+18.9%)
Jun 1998
-
-$2.85M(-31.3%)
-$12.64M(+4.6%)
Mar 1998
-
-$4.15M(+38.8%)
-$12.09M(+21.1%)
Dec 1997
-$9.98M(+0.7%)
-$2.99M(+12.8%)
-$9.98M(-3.9%)
Sep 1997
-
-$2.65M(+15.4%)
-$10.39M(+3.5%)
Jun 1997
-
-$2.30M(+12.4%)
-$10.04M(-2.0%)
Mar 1997
-
-$2.04M(-39.9%)
-$10.24M(+1.4%)
Dec 1996
-$9.91M(+29.3%)
-$3.40M(+47.8%)
-$10.10M(+12.2%)
Sep 1996
-
-$2.30M(-8.0%)
-$9.00M(+7.1%)
Jun 1996
-
-$2.50M(+31.6%)
-$8.40M(+12.0%)
Mar 1996
-
-$1.90M(-17.4%)
-$7.50M(-3.8%)
Dec 1995
-$7.66M(+45.1%)
-$2.30M(+35.3%)
-$7.80M(0.0%)
Sep 1995
-
-$1.70M(+6.3%)
-$7.80M(+11.4%)
Jun 1995
-
-$1.60M(-27.3%)
-$7.00M(+11.1%)
Mar 1995
-
-$2.20M(-4.3%)
-$6.30M(+21.2%)
Dec 1994
-$5.28M
-$2.30M(+155.6%)
-$5.20M(+79.3%)
Sep 1994
-
-$900.00K(0.0%)
-$2.90M(+45.0%)
Jun 1994
-
-$900.00K(-18.2%)
-$2.00M(+81.8%)
Mar 1994
-
-$1.10M
-$1.10M

FAQ

  • What is Nektar Therapeutics annual net profit?
  • What is the all time high annual net income for Nektar Therapeutics?
  • What is Nektar Therapeutics annual net income year-on-year change?
  • What is Nektar Therapeutics quarterly net profit?
  • What is the all time high quarterly net income for Nektar Therapeutics?
  • What is Nektar Therapeutics quarterly net income year-on-year change?
  • What is Nektar Therapeutics TTM net profit?
  • What is the all time high TTM net income for Nektar Therapeutics?
  • What is Nektar Therapeutics TTM net income year-on-year change?

What is Nektar Therapeutics annual net profit?

The current annual net income of NKTR is -$118.96M

What is the all time high annual net income for Nektar Therapeutics?

Nektar Therapeutics all-time high annual net profit is $681.31M

What is Nektar Therapeutics annual net income year-on-year change?

Over the past year, NKTR annual net profit has changed by +$157.09M (+56.91%)

What is Nektar Therapeutics quarterly net profit?

The current quarterly net income of NKTR is -$41.59M

What is the all time high quarterly net income for Nektar Therapeutics?

Nektar Therapeutics all-time high quarterly net profit is $971.46M

What is Nektar Therapeutics quarterly net income year-on-year change?

Over the past year, NKTR quarterly net profit has changed by +$10.77M (+20.57%)

What is Nektar Therapeutics TTM net profit?

The current TTM net income of NKTR is -$122.27M

What is the all time high TTM net income for Nektar Therapeutics?

Nektar Therapeutics all-time high TTM net profit is $902.71M

What is Nektar Therapeutics TTM net income year-on-year change?

Over the past year, NKTR TTM net profit has changed by +$54.81M (+30.95%)
On this page